Literature DB >> 34242090

Transitioning to Telehealth During the COVID-19 Pandemic: Patient Perspectives and Attendance at an HIV Clinic in San Francisco.

Isabella C Auchus1, Katrin Jaradeh1, Alice Tang1,2, Jackie Marzan3, Bryn Boslett1,3.   

Abstract

Approximately 1.2 million people are living with HIV in the United States, with 16,000 in San Francisco. Many HIV-positive individuals have difficulty maintaining follow-up clinic visits under normal circumstances, and this is complicated by the coronavirus disease 2019 (COVID-19) pandemic as many institutions transition to a telehealth-focused model of care to maintain patient and provider safety. However, it was unknown how telehealth would impact patient attendance and perceptions about their care, particularly in populations at high risk of appointment nonattendance. To quantify the impact of telehealth on retention in care for a vulnerable HIV-infected population and to identify patient perspectives of telehealth and its effect on appointment attendance, we studied patients at the University of California, San Francisco (UCSF) 360 Wellness Center, an HIV primary care clinic in urban San Francisco, California. Anonymous surveys were conducted to assess patient perceptions of telehealth, and 21% of patients sent surveys responded. Appointment attendance rates for all visits were analyzed before and after the shelter-in-place order in San Francisco on March 16, 2020. With the transition to telehealth, the overall nonattendance rate decreased by ∼3%. Most common perceived strengths of telehealth included convenience and safety, whereas disadvantages included technical barriers and unfamiliarity. Despite barriers and disadvantages listed by patients, a majority are willing to attend telehealth visits, as 80.5% of respondents reported being equally or more likely to attend telehealth visits. This is a critical finding during the COVID-19 pandemic and beyond; we believe that telehealth can improve appointment attendance for vulnerable populations who often face barriers to receiving health care.

Entities:  

Keywords:  COVID-19; HIV; appointment attendance; telehealth; telemedicine

Mesh:

Year:  2021        PMID: 34242090      PMCID: PMC8418448          DOI: 10.1089/apc.2021.0075

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.944


  16 in total

Review 1.  Continuity of care: a multidisciplinary review.

Authors:  Jeannie L Haggerty; Robert J Reid; George K Freeman; Barbara H Starfield; Carol E Adair; Rachael McKendry
Journal:  BMJ       Date:  2003-11-22

2.  Exploring the Attitude of Patients with HIV About Using Telehealth for HIV Care.

Authors:  Dima Dandachi; Bich N Dang; Brandon Lucari; Michelle Teti; Thomas P Giordano
Journal:  AIDS Patient Care STDS       Date:  2020-04       Impact factor: 5.078

3.  Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic.

Authors:  M B Berg; S A Safren; M J Mimiaga; C Grasso; S Boswell; K H Mayer
Journal:  AIDS Care       Date:  2005-10

4.  Advantages and disadvantages for receiving Internet-based HIV/AIDS interventions at home or at community-based organizations.

Authors:  Shana M Green; Elizabeth Lockhart; Stephanie L Marhefka
Journal:  AIDS Care       Date:  2015-09-11

Review 5.  The end of AIDS: HIV infection as a chronic disease.

Authors:  Steven G Deeks; Sharon R Lewin; Diane V Havlir
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

6.  A pandemic of the poor: social disadvantage and the U.S. HIV epidemic.

Authors:  Jennifer A Pellowski; Seth C Kalichman; Karen A Matthews; Nancy Adler
Journal:  Am Psychol       Date:  2013 May-Jun

7.  Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States.

Authors:  Michael A Horberg; Leo B Hurley; Michael J Silverberg; Daniel B Klein; Charles P Quesenberry; Michael J Mugavero
Journal:  AIDS Patient Care STDS       Date:  2013-07-19       Impact factor: 5.078

8.  Adapting to the COVID-19 Pandemic: Continuing HIV Prevention Services for Adolescents Through Telemonitoring, Brazil.

Authors:  Inês Dourado; Laio Magno; Fabiane Soares; Paula Massa; Amy Nunn; Shona Dalal; Alexandre Grangeiro
Journal:  AIDS Behav       Date:  2020-07

9.  Telehealth transformation: COVID-19 and the rise of virtual care.

Authors:  Jedrek Wosik; Marat Fudim; Blake Cameron; Ziad F Gellad; Alex Cho; Donna Phinney; Simon Curtis; Matthew Roman; Eric G Poon; Jeffrey Ferranti; Jason N Katz; James Tcheng
Journal:  J Am Med Inform Assoc       Date:  2020-06-01       Impact factor: 4.497

10.  It is Time to Include Telehealth in Our Measure of Patient Retention in HIV Care.

Authors:  Dima Dandachi; Jennifer Freytag; Thomas P Giordano; Bich N Dang
Journal:  AIDS Behav       Date:  2020-09
View more
  9 in total

1.  Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study.

Authors:  Joseph G Rosen; Leanne Zhang; Danielle Pelaez; Jenell S Coleman; C To; Lyra Cooper; Praise F Olatunde; Teagan Toomre; Jennifer L Glick; Ju Nyeong Park
Journal:  AIDS Patient Care STDS       Date:  2022-08       Impact factor: 5.944

2.  Lost2PrEP: Understanding Reasons for Pre-Exposure Prophylaxis and Sexual Health Care Disengagement Among Men Who Have Sex with Men Attending a Sexual Health Clinic at a Large Urban Academic Medical Center in New York City.

Authors:  Kelly Rowe; Deborah A Theodore; Jason Zucker; Omid Cohensedgh; Elijah LaSota; Caroline Carnevale; Alwyn Cohall; Susan Olender; Peter Gordon; Magdalena E Sobieszczyk
Journal:  AIDS Patient Care STDS       Date:  2022-04       Impact factor: 5.944

3.  Health Care Providers' and Professionals' Experiences With Telehealth Oncology Implementation During the COVID-19 Pandemic: A Qualitative Study.

Authors:  Kea Turner; Margarita Bobonis Babilonia; Cristina Naso; Oliver Nguyen; Brian D Gonzalez; Laura B Oswald; Edmondo Robinson; Jennifer Elston Lafata; Robert J Ferguson; Amir Alishahi Tabriz; Krupal B Patel; Julie Hallanger-Johnson; Nasrin Aldawoodi; Young-Rock Hong; Heather S L Jim; Philippe E Spiess
Journal:  J Med Internet Res       Date:  2022-01-19       Impact factor: 5.428

4.  Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium.

Authors:  Thibaut Vanbaelen; Anke Rotsaert; Bart K M Jacobs; Eric Florence; Chris Kenyon; Bea Vuylsteke; Marie Laga; Reyniers Thijs
Journal:  AIDS Patient Care STDS       Date:  2022-04       Impact factor: 5.944

5.  Age and Racial Disparities in Telehealth Use Among People with HIV During the COVID-19 Pandemic.

Authors:  Eleanor E Friedman; Samantha A Devlin; Sarah F Gilson; Jessica P Ridgway
Journal:  AIDS Behav       Date:  2022-02-08

Review 6.  Impact of the COVID-19 Pandemic on HIV Healthcare Service Engagement, Treatment Adherence, and Viral Suppression in the United States: A Systematic Literature Review.

Authors:  Sarah E Slone; Oluwabunmi Ogungbe; Brenice Duroseau; Diane Meyer; Jason E Farley
Journal:  AIDS Behav       Date:  2022-08-02

Review 7.  Transgender Individuals and Digital Health.

Authors:  Asa E Radix; Keosha Bond; Pedro B Carneiro; Arjee Restar
Journal:  Curr HIV/AIDS Rep       Date:  2022-09-22       Impact factor: 5.495

Review 8.  HIV Care Meets Telehealth: a Review of Successes, Disparities, and Unresolved Challenges.

Authors:  Titilola Labisi; Nichole Regan; Precious Davis; Nada Fadul
Journal:  Curr HIV/AIDS Rep       Date:  2022-09-05       Impact factor: 5.495

9.  COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts.

Authors:  Catherine R Lesko; Jeanne C Keruly; Richard D Moore; Nicola M Shen; Jarratt D Pytell; Bryan Lau; Anthony T Fojo; Shruti H Mehta; Michele Kipke; Marianna K Baum; Steven Shoptaw; Pamina M Gorbach; Brian Mustanski; Marjan Javanbakht; Suzanne Siminski; Geetanjali Chander
Journal:  Drug Alcohol Depend       Date:  2022-02-12       Impact factor: 4.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.